These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12048360)

  • 1. Male sexual dysfunction associated with antiretroviral therapy.
    Colson AE; Keller MJ; Sax PE; Pettus PT; Platt R; Choo PW
    J Acquir Immune Defic Syndr; 2002 May; 30(1):27-32. PubMed ID: 12048360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and antiviral effect of protease inhibitors in children.
    Temple ME; Koranyi KI; Nahata MC
    Pharmacotherapy; 2001 Mar; 21(3):287-94. PubMed ID: 11253853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors.
    Lai S; Lai H; Celentano DD; Vlahov D; Ren S; Margolick J; Lima JA; Bartlett JG
    AIDS Patient Care STDS; 2003 May; 17(5):211-9. PubMed ID: 12816615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released].
    Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ritonavir plus saquinavir- and nelfinavir plus saquinavir-containing regimens as salvage therapy in children with human immunodeficiency type 1 infection.
    Hoffmann F; Notheis G; Wintergerst U; Eberle J; Gürtler L; Belohradsky BH
    Pediatr Infect Dis J; 2000 Jan; 19(1):47-51. PubMed ID: 10643850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
    Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
    Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group.
    Bonfanti P; Valsecchi L; Parazzini F; Carradori S; Pusterla L; Fortuna P; Timillero L; Alessi F; Ghiselli G; Gabbuti A; Di Cintio E; Martinelli C; Faggion I; Landonio S; Quirino T
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):236-45. PubMed ID: 10839659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment.
    Schrooten W; Colebunders R; Youle M; Molenberghs G; Dedes N; Koitz G; Finazzi R; de Mey I; Florence E; Dreezen C;
    AIDS; 2001 May; 15(8):1019-23. PubMed ID: 11399984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients.
    Chronister CL; Gurwood AS
    J Am Optom Assoc; 1998 Nov; 69(11):695-8. PubMed ID: 9844321
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of protease inhibitors on the sense of taste.
    Schiffman SS; Zervakis J; Heffron S; Heald AE
    Nutrition; 1999 Oct; 15(10):767-72. PubMed ID: 10501290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
    Baldini F; Di Giambenedetto S; Cingolani A; Murri R; Ammassari A; De Luca A
    AIDS; 2000 Jul; 14(11):1660-2. PubMed ID: 10983656
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications.
    Kaul DR; Cinti SK; Carver PL; Kazanjian PH
    Pharmacotherapy; 1999 Mar; 19(3):281-98. PubMed ID: 10221367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
    Rudin C; Burri M; Shen Y; Rode R; Nadal D; ;
    Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavir.
    Vandercam B; Moreau M; Horsmans C; Gala JL
    Infection; 1998; 26(5):313. PubMed ID: 9795794
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.
    Kirk O; Katzenstein TL; Gerstoft J; Mathiesen L; Nielsen H; Pedersen C; Lundgren JD
    AIDS; 1999 Jan; 13(1):F9-16. PubMed ID: 10207539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia under treatment with proteinase inhibitors.
    Segerer S; Bogner JR; Walli R; Loch O; Goebel FD
    Infection; 1999; 27(2):77-81. PubMed ID: 10219634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of HIV protease inhibitor: indinavir is currently the best option.
    Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.